CANDESARTAN-AMLODIPI Mepha caps 16mg/5mg 98 pce
7680676560041
CH-67656
C09DB07
02.07.1.
Reimbursement limitations:
CANDESART-AM
Le traitement combiné d’une association fixe de candésartan et amlodipine et d'un antagoniste du calcium …
1 / 3
google
Details
- Product number
- 6765602
- CPT
- -
- Packaging group
- 98
- Unit
- Kapsel(n)
- Composition
- candesartanum cilexetilum 16 mg, amlodipinum 5 mg ut amlodipini besilas, lactosum monohydricum 203.9 mg, maydis amylum, carmellosum calcicum, macrogolum 8000, hydroxypropylcellulosum, magnesii stearas, Kapselhülle: E 104, E 171, gelatina, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.
Articles (1)
Candesartan-Amlodipin-Mepha 16 mg/5 mg, Hartkapseln
Kapseln
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
16.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
203.9 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 70.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2021
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67656
- Drug name
- Candesartan-Amlodipin-Mepha, Hartkapseln
- Galenic form
- KAPS
- ATC Code
- C09DB07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CANDESARTAN-AMLODIPI Mepha caps 16mg/5mg 98 pce
- Description (DE)
- CANDESARTAN-AMLODIP Mepha Kaps 16mg/5mg 98 Stk
- Market launch
- 23/12/2020
- Narcotic (BTM)
- No